0001646819-18-000001.txt : 20181128 0001646819-18-000001.hdr.sgml : 20181128 20181127215925 ACCESSION NUMBER: 0001646819-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181128 DATE AS OF CHANGE: 20181127 EFFECTIVENESS DATE: 20181128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gladius Pharmaceuticals Corp CENTRAL INDEX KEY: 0001646819 IRS NUMBER: 432119667 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326665 FILM NUMBER: 181204076 BUSINESS ADDRESS: STREET 1: 2711 CENTERVILLE ROAD, SUITE 400 STREET 2: COUNTY NEWCASTLE CITY: WILMINGTON STATE: DE ZIP: 19808 BUSINESS PHONE: 514-213-4456 MAIL ADDRESS: STREET 1: 2711 CENTERVILLE ROAD, SUITE 400 STREET 2: COUNTY NEWCASTLE CITY: WILMINGTON STATE: DE ZIP: 19808 D 1 primary_doc.xml X0708 D LIVE 0001646819 Gladius Pharmaceuticals Corp 2711 CENTERVILLE ROAD, SUITE 400 COUNTY NEWCASTLE WILMINGTON DE DELAWARE 19808 514-213-4456 DELAWARE None None Corporation true 2015 Michael Atkin 2711 Centerville Rd., Suite 400 Wilmington DE DELAWARE 19808 Executive Officer Larry Sutton 2711 Centerville Rd., Suite 400 Wilmington DE DELAWARE 19808 Director Daniel Hetu 2711 Centerville Rd., Suite 400 Wilmington DE DELAWARE 19808 Director Jens Eckstein 2711 Centerville Rd., Suite 400 Wilmington DE DELAWARE 19808 Director Nathalie Chauret 2711 Centerville Rd., Suite 400 Wilmington DE DELAWARE 19808 Director Biotechnology Decline to Disclose 06b false 2018-11-14 false true true false 0 3022400 3022400 0 The offering amount is based on the exchange rate of C$1 to US$0.7556 on November 14, 2018. false 5 0 0 0 false Gladius Pharmaceuticals Corp Michael Atkin Michael Atkin President and Secretary 2018-11-27